Fertility and IVF: Clinics, Costs, Egg Freezing and the Law — 2026-09-11
This week, South Korean provinces and municipalities announced significant shifts in fertility support, with Gyeonggi Province consolidating resources into a ₩95.6 billion infertility fund and Gangneung launching a unique "top-up" subsidy for exhausted government limits. In the US, the employer fertility stop-loss insurance market is projected to reach $2.48 billion by 2030, while WIRED investigated the ethical complexities of "free" egg freezing startups like Cofertility. Meanwhile, ESHRE released its first major laboratory standards update in 11 years, impacting global IVF success rates.
Fertility and IVF: Clinics, Costs, Egg Freezing and the Law — 2026-09-11
Top developments
Gyeonggi Province Consolidates ₩95.6 Billion for Infertility Support
On September 9, Gyeonggi Province announced it will end its postpartum care subsidy of ₩500,000 after September 30 to redirect funds toward infertility treatment. The province is increasing its infertility procedure support budget to ₩95.6 billion (approx. $70 million) for the year. This move reflects a strategic pivot from general maternal care to targeted assisted reproductive technology (ART) support, aiming to address low birth rates by lowering financial barriers for IVF and artificial insemination cycles.
Gangneung Launches "Top-Up" Subsidy for Exhausted Government Limits
On September 7, Gangneung City in Gangwon Province announced the "Gangneung-type Infertility Couple Procedure Cost Support Project." This initiative provides up to five additional cycles of procedure costs for couples who have exhausted their national government support limits. This local-level intervention addresses the gap where national subsidies run out but patients still require multiple cycles to achieve success, potentially boosting local clinic volumes and patient retention.
US Employer Fertility Stop-Loss Insurance Market Projected to Hit $2.48 Billion
A new report published on September 9 projects that the employer fertility stop-loss insurance market will reach $2.48 billion by 2030. This segment is expanding rapidly as companies seek to mitigate the financial risk of high-cost ART procedures while offering competitive employee benefits. The growth signals a shift where employers are moving beyond simple coverage mandates to sophisticated risk-management products for IVF and egg freezing.
WIRED Investigates Cofertility’s "Free" Egg Freezing Model
WIRED published an exposé on September 9 regarding Cofertility, a startup that offers egg freezing for free in exchange for half the retrieved eggs. The investigation highlights the ethical and legal ambiguities of this "split-cycle" model, particularly concerning donor anonymity and the psychological impact on clients who may later discover their eggs were used by others. This story raises critical questions about consent and ownership in emerging fertility business models.
ESHRE Releases New Laboratory Standards for IVF
The European Society of Human Reproduction and Embryology (ESHRE) released updated guidelines on September 7, marking the first major revision of its laboratory standards in 11 years. The new standards focus on optimizing the "culture room" environment, which is critical for embryo development and subsequent success rates. These updates are expected to influence clinic operations globally, including in South Korea, where adoption of international best practices can improve live birth rates per cycle.
Local view
In South Korea, local media and stakeholders are focusing heavily on the integration of physical treatment with mental and lifestyle support. Seoul Metropolitan Council member Park Chun-seon emphasized during a budget review on September 9 that infertility support must extend beyond procedure costs to include psychological counseling and environmental adjustments throughout the pregnancy journey.
Additionally, Raportian reported on September 10 that as marriage and childbirth ages rise, the number of infertility diagnoses in Korea reached 304,011 in 2024, a 31% increase from 2020. The article highlights that for patients experiencing repeated implantation failure, uterine receptivity testing is becoming a crucial next step, driven by the need to maximize success rates in an aging demographic.
Context & numbers
- Gyeonggi Province Infertility Budget: ₩95.6 billion (2026).
- Gangneung Additional Support: Up to 5 extra cycles for eligible couples.
- US Stop-Loss Insurance Market: Projected $2.48 billion by 2030.
- Korea Infertility Diagnoses: 304,011 in 2024 (up 31% from 2020).
On the radar
- End of Gyeonggi Postpartum Subsidy: The current ₩500,000 postpartum care benefit ends for applications submitted after September 30, 2026. Patients and families should prepare for this transition.
- Cofertility Legal Scrutiny: Following the WIRED report, legal experts are watching for potential regulatory responses regarding the ownership and use of eggs in split-cycle models.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
